In an exciting step forward, dogs with Duchenne muscular dystrophy (DMD) were treated with the CRISPR genome editor to restore production of the missing protein responsible for the disease. After more studies to prove it is safe and effective long-term, this has the potential to move into clinical trials as a DMD therapy. “[The dogs] showed obvious signs of behavioral improvement – running, jumping – … Continue reading Dogs with muscular dystrophy receive CRISPR treatment: What does this mean for humans?